Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Koskinas

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Current Pharmaceutical Design|December 6, 2016
Antiplatelets and Antithrombotics in Patients with Liver Insufficiency: From Pathophysiology to Clinical PracticeMelanie Deutsch, John Koskinas
World Journal of Gastroenterology|September 26, 2014
Extrahepatic immune related manifestations in chronic hepatitis C virus infectionMaria Tampaki, John Koskinas
Journal of Clinical and Translational Hepatology|October 28, 2022
Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2Emmanouil S Koullias, John Koskinas
Cancers|March 11, 2023
Liquid Biopsies, Novel Approaches and Future DirectionsAthanasios Armakolas, Maria Kotsari, John Koskinas
Annals of Gastroenterology|November 3, 2018
Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issuesMaria Tampaki, Spiros Savvanis, John Koskinas
Virology|May 30, 2002
In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoterAndreas Laras, John Koskinas, Stephanos J Hadziyannis
Annals of Gastroenterology|January 2, 2019
Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitisGeorge N Dalekos, John Koskinas, George V Papatheodoridis
Oncology Reports|November 24, 2012
Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levelsEmilia Hadziyannis, Konstantinos Sialevris, Anastasia Georgiou, et al.
Hemoglobin|September 7, 2022
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion TherapyKonstantinos Manganas, Sophia Delicou, Aikaterini Xydaki, et al.
International Journal of Molecular Sciences|July 29, 2023
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC ProgressionMaria Kotsari, Vassiliki Dimopoulou, John Koskinas, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Current Pharmaceutical Design|December 6, 2016
Antiplatelets and Antithrombotics in Patients with Liver Insufficiency: From Pathophysiology to Clinical PracticeMelanie Deutsch, John Koskinas
World Journal of Gastroenterology|September 26, 2014
Extrahepatic immune related manifestations in chronic hepatitis C virus infectionMaria Tampaki, John Koskinas
Journal of Clinical and Translational Hepatology|October 28, 2022
Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2Emmanouil S Koullias, John Koskinas
Cancers|March 11, 2023
Liquid Biopsies, Novel Approaches and Future DirectionsAthanasios Armakolas, Maria Kotsari, John Koskinas
Annals of Gastroenterology|November 3, 2018
Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issuesMaria Tampaki, Spiros Savvanis, John Koskinas
Virology|May 30, 2002
In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoterAndreas Laras, John Koskinas, Stephanos J Hadziyannis
Annals of Gastroenterology|January 2, 2019
Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitisGeorge N Dalekos, John Koskinas, George V Papatheodoridis
Oncology Reports|November 24, 2012
Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levelsEmilia Hadziyannis, Konstantinos Sialevris, Anastasia Georgiou, et al.
Hemoglobin|September 7, 2022
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion TherapyKonstantinos Manganas, Sophia Delicou, Aikaterini Xydaki, et al.
International Journal of Molecular Sciences|July 29, 2023
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC ProgressionMaria Kotsari, Vassiliki Dimopoulou, John Koskinas, et al.
Pageof 10